The smart micro-needle works to detect serious underlying medical issues in the wearer as they go about their day-to-day life.
The investment is intended to fund human trials of a biological pancreas that produces insulin independently in the body and renders further injections unnecessary.
By incorporating Aidoc's AI platform, Novant Health is hoping to improve patient outcomes and reduce emergency department stays.
The new fund will be called “eHV Advanced” and will also invest in companies that have exited incubators after a period of five years.
Protai, which was only founded last year, has built an end-to-end AI-based platform that comprehensively maps the course of a disease on the protein level.
I believe that here, in Israel, where we have an excellent healthcare system and some of the best engineers in the world, we can be a biotech leader.
Several companies in Israel and around the world have identified the hot market and developed technologies that combine robotics and artificial intelligence, creating a new reality.
Medical technology acceleration fund Sofinnova MD Start III has invested $5 million in Israeli medical technology company Endoron Medical.
NanoPass’ microneedle device is based on MEMS (Micro Electro Mechanical Systems) technology and is made of pure silicon crystal.